We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPEC
5301
DELISTED
Spectaire Holdings, Inc. Common Stock
SPEC
$1.91K ﹤0.01%
1,160
+1,152
+14,400% +$4.46K
AINC
5302
DELISTED
Ashford Inc.
AINC
$1.91K ﹤0.01%
519
-218
-30% -$1.13K
TWAV
5303
TaoWeave Inc
TWAV
$4.7M
$1.89K ﹤0.01%
239
-1
-0.4% -$8
TV icon
5304
Televisa
TV
$1.52B
$1.88K ﹤0.01%
564
-430
-43% -$1.22K
CTV
5305
DELISTED
Innovid Corp.
CTV
$1.88K ﹤0.01%
+1,251
New +$1.59K
PBAXU
5306
DELISTED
Phoenix Biotech Acquisition Corp. Unit
PBAXU
$1.87K ﹤0.01%
175
NETD
5307
DELISTED
Nabors Energy Transition Corp II
NETD
$1.87K ﹤0.01%
180
+179
+17,900% +$1.84K
RHE
5308
DELISTED
Regional Health Properties, Inc.
RHE
$1.87K ﹤0.01%
923
-22
-2% -$43
KGC icon
5309
Kinross Gold
KGC
$32.5B
$1.86K ﹤0.01%
308
-16,130
-98% -$88.2K
SYRA
5310
DELISTED
Syra Health Corp. Class A Common Stock
SYRA
$1.86K ﹤0.01%
+1,829
New +$2.82K
YARW
5311
Yarrow Bioscience, Inc. Common Stock
YARW
$112M
$1.84K ﹤0.01%
16
+11
+220% +$1.71K
AOGOU
5312
DELISTED
Arogo Capital Acquisition Corp. Unit
AOGOU
$1.84K ﹤0.01%
156
KRP icon
5313
Kimbell Royalty Partners
KRP
$1.49B
$1.84K ﹤0.01%
+122
New +$1.91K
AAVM
5314
EA Series Trust Alpha Architect Global Factor Equity ETF
AAVM
$26.9M
$1.84K ﹤0.01%
+79
New +$1.78K
SDIV icon
5315
Global X SuperDividend ETF
SDIV
$1.22B
$1.83K ﹤0.01%
81
+23
+40% +$492
NCMI icon
5316
National CineMedia
NCMI
$370M
$1.82K ﹤0.01%
+440
New +$1.78K
UTG icon
5317
Reaves Utility Income Fund
UTG
$3.59B
$1.82K ﹤0.01%
68
+19
+39% +$486
BTEC
5318
DELISTED
Principal Exchange-Traded Funds Principal Healthcare Innovators ETF
BTEC
$1.82K ﹤0.01%
50
EPSN icon
5319
Epsilon Energy
EPSN
$176M
$1.81K ﹤0.01%
357
-6,207
-95% -$33.1K
TCON
5320
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$1.81K ﹤0.01%
518
-2
-0.4% -$7
NBSE
5321
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$1.81K ﹤0.01%
2,448
+16
+0.7% +$12
GILT icon
5322
Gilat Satellite Networks
GILT
$832M
$1.81K ﹤0.01%
+296
New +$1.84K
YSG
5323
Yatsen Holding
YSG
$312M
$1.81K ﹤0.01%
494
-1,625
-77% -$6.95K
DRRX
5324
DELISTED
DURECT Corp
DRRX
$1.79K ﹤0.01%
3,034
-600
-17% -$855
SPI
5325
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$1.78K ﹤0.01%
2,282
+2,182
+2,182% +$1.61K

Similar funds

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.